PUBLISHER: Grand View Research | PRODUCT CODE: 1908541
PUBLISHER: Grand View Research | PRODUCT CODE: 1908541
The global astaxanthin market size was estimated at USD 1.96 billion in 2025 and is anticipated to reach USD 4.27 billion by 2033, growing at a CAGR of 9.54% from 2026 to 2033. The growing demand for astaxanthin is being fueled by its increasing use in various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages, among others.
The rising awareness about nutrition for a healthy lifestyle and the increasing preference for dietary supplements owing to the high hospitalization cost are projected to drive the demand for nutraceuticals & natural antioxidants. The market players are significantly increasing their production capacities to compete with the growing demand for nutraceutical products. For instance, in April 2023, Algalif announced that its 12,500 m2 sustainable natural astaxanthin production facility in Iceland was progressing as planned. The USD 30 million expansion, initiated in summer 2021, is expected to be fully operational by the end of 2023. This significant investment underscores. Furthermore, in April 2022, Beijing Gingko Group announced a second expansion of its pristine region's astaxanthin farm capacity in the last 2 years, which would maximize its production capacity. Algatech Ltd. increased its production capacity threefold for FucoVital, a product derived from brown algae, to fulfill the increasing demand for the dietary supplements market.
The introduction of advanced technologies to increase astaxanthin production is expected to boost market growth. For instance, in March 2024, Kuehnle AgroSystems (KAS) secured USD 3 million in Series A2 funding, led by S2G Ventures. This investment aims to accelerate the commercialization of KAS's innovative approach to producing natural astaxanthin. Utilizing a patented dark fermentation process, KAS offers a solution that delivers higher yields, lower costs, and reduced resource consumption compared to conventional methods. This advancement supports the shift from synthetic to natural, addressing a market valued at USD 3.7 billion and driven by increasing consumer preference for natural, sustainable products.
Increasing concerns about the adverse effects of chemicals and the growing use of synthetic additives in edible products and topical applications are some of the factors responsible for the increasing adoption of natural alternatives. In August 2024, a study published in the Journal of Ovarian Research highlighted that astaxanthin (AST) supplementation could enhance assisted reproductive technology (ART) outcomes. The research found that AST improves oocyte quality and reduces oxidative stress (OS) in reproductive organs, supporting its role in promoting reproductive health. Astaxanthin's demonstrated ability to enhance oocyte quality and minimize oxidative damage reinforces its potential for pharmaceutical applications. As oxidative stress is a key factor in many health conditions, astaxanthin could see broader adoption in treatments for reproductive and other oxidative stress-related disorders.
Global Astaxanthin Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the astaxanthin market based on source, product, application, and region: